Volume 21, Issue 69 (8-2020)
Zanko J Med Sci 2020, 21(69): 78-88 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nasiri Saghayesh R. Assessment of neurofeedback on the executive function of children with ADHD treated by methylphenidate. Zanko J Med Sci 2020; 21 (69) :78-88
URL: http://zanko.muk.ac.ir/article-1-509-en.html
URL: http://zanko.muk.ac.ir/article-1-509-en.html
Abstract: (2883 Views)
Background and Aim: Attention Deficit Hyperactivity Disorder is one of the most common neuropsychiatric disorders in childhood and has affected a large proportion of the world's population. Given the advancement of neurocognitive science, behavioral therapy, cognitive behavioral therapy and their effect on the treatment of psychiatric illnesses, the need for recovery of the disorder as soon as possible, the attention to the neuro-behavioral cause of the disorder and also the existence of various studies on the combination therapy of pharmacological and non-pharmacological treatment were enough reasons for us to do some researches on the field of neurofeedback-pharmacological combination therapy. Our aim of this study was to investigate therapeutic effect of methylphenidate with neurofeedback on the executive function of children with ADHD in specialized and sub-specialized psychiatric clinics of Tabriz medical science facility.
Material and Method: The present study is a randomized triple-blind clinical trial with a parallel two-way design. The statistical population consists of clients with attention-deficit/hyperactivity disorder (ADHD) who have referred to the specialized and sub-specialized psychiatric clinics of Tabriz medical science facility. 40 patients among the hundreds of eligible cases were selected by creating a random alternate sequence and subjected to blockade in one of two groups of 20 (methylphenidate or methylphenidate with neurofeedback). Samples were studied once at the beginning of the study and again after the completion of the treatment with Parents' Conners Questionnaire and Continuous Performance Test (CPT-2). Data were analyzed using SPSS 19 software and P-value <0.05.
Results: In the methylphenidate and methylphenidate with neurofeedback groups, there was a significant pre-treatment and post-treatment difference in the reduction of key-symptoms of hyperactivity, attention/recognition, Conner's disobedience/impulsivity, perpetration error, deletion error, and response time of the function. The methylphenidate with neurofeedback group had a significantly higher improvement rate.
Conclusion: The results suggest that the highest frequency of the participants in terms of gender was males (34 males, 6 female) and in terms of education level was in primary, pre-school and junior school respectively. The average age of participants was 9.2+2.38 . Furthermore, the research indicated that treatment by methylphenidate with neurofeedback had a significantly higher improvement rate in the reduction of key-symptoms of hyperactivity, attention/recognition, Conner's disobedience/impulsivity, and improved performance in children with ADHD (perpetration error, deletion error, and response time of the function) than methylphenidate alone.
Material and Method: The present study is a randomized triple-blind clinical trial with a parallel two-way design. The statistical population consists of clients with attention-deficit/hyperactivity disorder (ADHD) who have referred to the specialized and sub-specialized psychiatric clinics of Tabriz medical science facility. 40 patients among the hundreds of eligible cases were selected by creating a random alternate sequence and subjected to blockade in one of two groups of 20 (methylphenidate or methylphenidate with neurofeedback). Samples were studied once at the beginning of the study and again after the completion of the treatment with Parents' Conners Questionnaire and Continuous Performance Test (CPT-2). Data were analyzed using SPSS 19 software and P-value <0.05.
Results: In the methylphenidate and methylphenidate with neurofeedback groups, there was a significant pre-treatment and post-treatment difference in the reduction of key-symptoms of hyperactivity, attention/recognition, Conner's disobedience/impulsivity, perpetration error, deletion error, and response time of the function. The methylphenidate with neurofeedback group had a significantly higher improvement rate.
Conclusion: The results suggest that the highest frequency of the participants in terms of gender was males (34 males, 6 female) and in terms of education level was in primary, pre-school and junior school respectively. The average age of participants was 9.2+2.38 . Furthermore, the research indicated that treatment by methylphenidate with neurofeedback had a significantly higher improvement rate in the reduction of key-symptoms of hyperactivity, attention/recognition, Conner's disobedience/impulsivity, and improved performance in children with ADHD (perpetration error, deletion error, and response time of the function) than methylphenidate alone.
Type of Study: Research |
Subject:
Special
Received: 2020/04/5 | Accepted: 2020/06/1 | ePublished: 2020/08/31
Received: 2020/04/5 | Accepted: 2020/06/1 | ePublished: 2020/08/31
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
